Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
06.02.2020 14:58:13

Conduent Market-Leading Disease Surveillance and Outbreak Management System to Fight Coronavirus

Company’s Flexible Platform, Maven®, Already Customized and Implemented by Government and Health Organizations to Track, Manage and Report Confirmed Coronavirus Cases

Conduent to Configure and Deploy Coronavirus Tracking Module for Additional Government and Health Organizations Seeking Support

FLORHAM PARK, N.J., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT) today announced a version of its disease surveillance and outbreak management platform, Maven®, to securely track, manage and report on cases of the coronavirus, 2019-nCov.

Maven is a software platform developed for organizations, including government agencies, to manage cases of more than 90 communicable diseases. Its flexible design gives organizations the capability to customize disease tracking most prevalent in specific geographies or communities. 

Conduent will host the platform’s coronavirus-enabled version of Maven in the company’s secure cloud so public health agencies and other organizations can get immediate access to use it. Conduent expects its coronavirus module to be available within the month. Additionally, those with advanced training also can leverage the solution’s flexibility to customize the Maven platform on their own to track coronavirus.

Based on an organization’s need, Maven has the capability to track diseases such as influenza, tuberculosis and Ebola. More than 40 organizations are currently using Maven, and some have already taken advantage of the platform’s flexibility by configuring it to track the coronavirus’s spread within their respective locations. Conduent is also actively facilitating sharing of best practices between clients as they configure their systems to track the outbreak.

"Maven is a valuable tool that organizations can use to identify and follow up on people who may have come into contact with a person infected with a communicable or infectious disease,” said Mark Brewer, President, Global Public Sector Solutions, Conduent. "In the absence of a vaccine, tracking and analyzing who is at risk from contact with an infected person is one of the most important methods available to contain diseases like the coronavirus and prevent widespread outbreaks.

"Maven’s technology is scalable and can be quickly and easily configured to changing technologies, protocols and geographic locations — all of which are keys to effective disease outbreak response. It is also designed to allow for easier data sharing and integration among health agencies on the front lines of battling the disease.”

Designed with rich contact tracing, outbreak management and detection, state and local health organizations can collaborate to quickly and effectively contain public health crises. Epidemiologists can use Maven’s reporting capability to search and analyze the centralized data collected to discover trends and patterns. Maven can also be used to report externally, supporting the need for automatic case reporting to the Centers for Disease Control and Prevention in the United States, the World Health Organization, or local authorities.

About Conduent  
Conduent delivers mission-critical ?services and solutions on behalf of businesses and governments – creating exceptional outcomes for its clients and the millions of people who count on them. Through people, process and technology, Conduent solutions and services automate workflows, improve efficiencies, reduce costs and enable revenue growth. It’s why most Fortune 100 companies and over 500 government entities depend on Conduent every day to manage their essential interactions and move their operations forward. 

Conduent’s differentiated services and solutions improve experiences for millions of people every day, including two-thirds of all?insured patients?in the U.S., 11 million employees who use its HR Services, and nearly nine million people who travel through?toll systems?daily. Conduent’s solutions deliver exceptional outcomes for its clients including $16 billion in medical bill savings, up to 40% efficiency increase in HR operations, and up to 40% improvement in processing costs, while driving higher end-user satisfaction. Learn more at www.conduent.com

Media Contacts:
Sean Collins, Conduent, +1-310-497-9205, sean.collins2@conduent.com
Neil Franz, Conduent, +1-301-820-4324, neil.franz@conduent.com

Investor Relations Contacts:
Alan Katz, Conduent, +1-973-526-7173, alan.katz@conduent.com
Rebecca Koar, Conduent, +1-862-308-7105, rebecca.koar@conduent.com

Note: To receive RSS news feeds, visit www.news.conduent.com. For open commentary, industry perspectives and views, visit http://twitter.com/Conduent, http://www.linkedin.com/company/conduent or http://www.facebook.com/Conduent.

Conduent is a trademark of Conduent Incorporated in the United States and/or other countries.

Analysen zu Conduent Inc Registered Shs When Issuedmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Conduent Inc Registered Shs When Issued 3,54 1,72% Conduent Inc Registered Shs When Issued